221 related articles for article (PubMed ID: 8913444)
1. In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis.
Fournet A; Ferreira ME; Rojas De Arias A; Torres De Ortiz S; Fuentes S; Nakayama H; Schinini A; Hocquemiller R
Antimicrob Agents Chemother; 1996 Nov; 40(11):2447-51. PubMed ID: 8913444
[TBL] [Abstract][Full Text] [Related]
2. 2-substituted quinoline alkaloids as potential antileishmanial drugs.
Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Cavé A; Bruneton J
Antimicrob Agents Chemother; 1993 Apr; 37(4):859-63. PubMed ID: 8494383
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases.
Nakayama H; Loiseau PM; Bories C; Torres de Ortiz S; Schinini A; Serna E; Rojas de Arias A; Fakhfakh MA; Franck X; Figadère B; Hocquemiller R; Fournet A
Antimicrob Agents Chemother; 2005 Dec; 49(12):4950-6. PubMed ID: 16304157
[TBL] [Abstract][Full Text] [Related]
4. Oral delivery of meglumine antimoniate-beta-cyclodextrin complex for treatment of leishmaniasis.
Demicheli C; Ochoa R; da Silva JB; Falcão CA; Rossi-Bergmann B; de Melo AL; Sinisterra RD; Frézard F
Antimicrob Agents Chemother; 2004 Jan; 48(1):100-3. PubMed ID: 14693525
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.
Patrício FJ; Costa GC; Pereira PV; Aragão-Filho WC; Sousa SM; Frazão JB; Pereira WS; Maciel MC; Silva LA; Amaral FM; Rebêlo JM; Guerra RN; Ribeiro MN; Nascimento FR
J Ethnopharmacol; 2008 Jan; 115(2):313-9. PubMed ID: 18035510
[TBL] [Abstract][Full Text] [Related]
6. Activity of compounds isolated from Chilean lichens against experimental cutaneous leishmaniasis.
Fournet A; Ferreira ME; Rojas de Arias A; Torres de Ortiz S; Inchausti A; Yaluff G; Quilhot W; Fernandez E; Hidalgo ME
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1997 Jan; 116(1):51-4. PubMed ID: 9080673
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis.
Solomon M; Ollech A; Pavlotsky F; Barzilai A; Schwartz E; Baum S; Astman N
Acta Derm Venereol; 2024 Apr; 104():adv35089. PubMed ID: 38682801
[TBL] [Abstract][Full Text] [Related]
8. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
Shazad B; Abbaszadeh B; Khamesipour A
Eur J Dermatol; 2005; 15(2):85-7. PubMed ID: 15757817
[TBL] [Abstract][Full Text] [Related]
9. The activity of 2-substituted quinoline alkaloids in BALB/c mice infected with Leishmania donovani.
Fournet A; Gantier JC; Gautheret A; Leysalles L; Munos MH; Mayrargue J; Moskowitz H; Cavé A; Hocquemiller R
J Antimicrob Chemother; 1994 Mar; 33(3):537-44. PubMed ID: 8040117
[TBL] [Abstract][Full Text] [Related]
10. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
Bogenrieder T; Lehn N; Landthaler M; Stolz W
Dermatology; 2003; 206(3):269-72. PubMed ID: 12673089
[TBL] [Abstract][Full Text] [Related]
12. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study.
Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J
Biomed Pharmacother; 2007; 61(2-3):148-53. PubMed ID: 17254746
[TBL] [Abstract][Full Text] [Related]
13. Disseminated American cutaneous leishmaniasis.
Bonfante-Garrido R; Barroeta S; de Alejos MA; Meléndez E; Torrealba J; Valdivia O; Momen H; Grimaldi Júnior G
Int J Dermatol; 1996 Aug; 35(8):561-5. PubMed ID: 8854152
[TBL] [Abstract][Full Text] [Related]
14. Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis.
Lanza JS; Fernandes FR; Corrêa-Júnior JD; Vilela JM; Magalhães-Paniago R; Ferreira LA; Andrade MS; Demicheli C; Melo MN; Frézard F
Int J Nanomedicine; 2016; 11():2305-18. PubMed ID: 27307731
[TBL] [Abstract][Full Text] [Related]
15. Leishmania amazonensis: effects of oral treatment with copaiba oil in mice.
dos Santos AO; Costa MA; Ueda-Nakamura T; Dias-Filho BP; da Veiga-Júnior VF; de Souza Lima MM; Nakamura CV
Exp Parasitol; 2011 Oct; 129(2):145-51. PubMed ID: 21771592
[TBL] [Abstract][Full Text] [Related]
16. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
Moosavi Z; Nakhli A; Rassaii S
Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
[No Abstract] [Full Text] [Related]
17. Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis.
Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Cavé A
Trop Med Parasitol; 1992 Dec; 43(4):219-22. PubMed ID: 1293723
[TBL] [Abstract][Full Text] [Related]
18. [Intralesional treatment of cutaneous leishmaniasis: a report of two cases].
Clarós P; Wienberg P; González MA; Clarós A; Clavería MA; López P
Acta Otorrinolaringol Esp; 1996; 47(1):67-70. PubMed ID: 8645493
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacies of two antimony regimens to treat Leishmania braziliensis-induced cutaneous Leishmaniasis in rhesus macaques (Macaca mulatta).
Grimaldi G; Porrozzi R; Friedrich K; Teva A; Marchevsky RS; Vieira F; Miekeley N; Paumgartten FJ
Antimicrob Agents Chemother; 2010 Jan; 54(1):502-5. PubMed ID: 19822700
[TBL] [Abstract][Full Text] [Related]
20. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
